Anna López-Ferrer Selected Research

Lewis Blood Group Antigens

7/2007	Changes in the invasive and metastatic capacities of HT-29/M3 cells induced by the expression of fucosyltransferase 1.
11/2002	Differences in the O-glycosylation patterns between lung squamous cell carcinoma and adenocarcinoma.
1/2002	The expression of human FUT1 in HT-29/M3 colon cancer cells instructs the glycosylation of MUC1 and MUC5AC apomucins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna López-Ferrer Research Topics

Disease

12	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022 - 01/2012
2	Neoplasms (Cancer) 07/2007 - 11/2002
2	Colonic Neoplasms (Colon Cancer) 07/2007 - 01/2002
2	Adenocarcinoma 03/2005 - 11/2002
1	Obesity 06/2016
1	Candidiasis (Moniliasis) 01/2015
1	Infections 01/2015
1	Pityriasis Rubra Pilaris 03/2014
1	Arthritis (Polyarthritis) 01/2012
1	Exanthema (Rash) 01/2012
1	Necrosis 01/2012
1	Sarcoidosis (Schaumann Disease) 01/2012
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2012
1	Psoriatic Arthritis 01/2012
1	Pityriasis Lichenoides (Pityriasis Lichenoides et Varioliformis Acuta) 07/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2002
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2002

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 06/2022 - 01/2012
3	guselkumabIBA 06/2022 - 01/2022
3	Ustekinumab (CNTO 1275)FDA Link 05/2020 - 01/2012
3	Etanercept (Enbrel)FDA Link 10/2019 - 01/2015
3	secukinumabIBA 08/2019 - 01/2015
3	Lewis Blood Group AntigensIBA 07/2007 - 01/2002
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
2	Infliximab (Remicade)FDA Link 10/2019 - 07/2010
2	Adalimumab (Humira)FDA Link 10/2019 - 01/2012
2	Biological ProductsIBA 11/2017 - 06/2016
2	CarbohydratesIBA 03/2005 - 11/2002
1	Biosimilar PharmaceuticalsIBA 10/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2015
1	CytokinesIBA 01/2015
1	Monoclonal AntibodiesIBA 01/2015
1	Acitretin FDA Link 03/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2014
1	Tumor Necrosis Factor InhibitorsIBA 01/2012
1	Therapeutic UsesIBA 01/2012
1	Methotrexate (Mexate)FDA LinkGeneric 07/2010
1	Sialyl Lewis X AntigenIBA 07/2007
1	FucosyltransferasesIBA 07/2007
1	AntigensIBA 07/2007
1	SialyltransferasesIBA 03/2005
1	Messenger RNA (mRNA)IBA 03/2005
1	GlycosyltransferasesIBA 11/2002
1	Periodic AcidIBA 11/2002
1	MucinsIBA 11/2002
1	Amylases FDA Link 11/2002

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2012
1	Biological Therapy 06/2022
1	Photochemotherapy (Photodynamic Therapy) 03/2014